Sharareh Gholamin

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Sharareh Gholamin, Siddhartha S. Mitra, Abdullah H. Feroze et al. · Science Translational Medicine · 2017 · 413 citations

BET Bromodomain Inhibition of <i>MYC</i> -Amplified Medulloblastoma

Pratiti Bandopadhayay, Guillaume Bergthold, Brian T. Nguyen et al. · Clinical Cancer Research · 2013 · 341 citations · Full text

Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo

Michael Zhang, Gregor Hütter, Suzana Assad Kahn et al. · PLoS ONE · 2016 · 320 citations · Full text

Neuro-oncology, Cancer Immunosurveillance, M1 Macrophages +14

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition

Yujie Tang, Sharareh Gholamin, Simone Schubert et al. · Nature Medicine · 2014 · 304 citations · Full text

Chromatin, Transcriptional Regulation, Epigenetic Targeting +12

Gpr124 is essential for blood–brain barrier integrity in central nervous system disease

Junlei Chang, Michael R. Mancuso, Carolina M. Maier et al. · Nature Medicine · 2017 · 251 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Neurobiology Of Disease +14